GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Net Income Including Noncontrolling Interests

Optimind Pharma (XCNQ:OMND) Net Income Including Noncontrolling Interests : C$-2.68 Mil (TTM As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Optimind Pharma's Net Income Including Noncontrolling Interests for the three months ended in Nov. 2023 was C$-0.10 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Nov. 2023 was C$-2.68 Mil.

Optimind Pharma Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Optimind Pharma's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Net Income Including Noncontrolling Interests Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23
Net Income Including Noncontrolling Interests
- -3.08

Optimind Pharma Quarterly Data
Jun21 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial -0.32 -1.98 -0.40 -0.18 -0.10

Optimind Pharma Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Optimind Pharma Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
XCNQ:NLV TSXV:GENX XCNQ:AYUR XCNQ:PHRX XCNQ:J XCNQ:CRCC XCNQ:BCBC XCNQ:CVGR XCNQ:PBF TSXV:HMPG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Website
https://www.optimindpharma.com
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines